Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX)

14 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,016,174 shares of 26,981,829 outstanding shares and own 3.8% of the company stock.
Largest 10 shareholders include Anson Funds Management LP (319,280 shares), SABBY MANAGEMENT, LLC (305,224 shares), RENAISSANCE TECHNOLOGIES LLC (137,000 shares), UBS Group AG (61,448 shares), TWO SIGMA SECURITIES, LLC (52,637 shares), CITADEL ADVISORS LLC (52,176 shares), HRT FINANCIAL LP (39,644 shares), GEODE CAPITAL MANAGEMENT, LLC (20,185 shares), TWO SIGMA INVESTMENTS, LP (11,004 shares), and Jump Financial, LLC (10,380 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.